Dr. Stephanie Venn-Watson is Co-Founder and CEO of Seraphina Therapeutics, a health and wellness company that develops groundbreaking essential fatty acids to help people age healthier. Stephanie is a veterinary epidemiologist and the world’s leading expert on C15:0, the first essential fatty acid to be discovered in over 90 years. Stephanie previously served as an epidemiologist for the World Health Organization and U.S. Navy. With over 60 patents and 80 peer-reviewed scientific publications, her novel approach to discovering nutrient-based therapeutics has been featured on NPR’s Science Friday, CBS, BBC, and National Geographic.